OmniVis: Difference between revisions
Content deleted Content added
m reserach > research |
GreenC bot (talk | contribs) Move 1 url. Wayback Medic 2.5 per WP:URLREQ#social.techcrunch.com |
||
| (One intermediate revision by one other user not shown) | |||
| Line 12: | Line 12: | ||
}} |
}} |
||
[[File:TechCrunch Disrupt San Francisco 2019 - Day 1 (48834421858).jpg|thumb|Dr Katherine Clayton of OmniVis at [[TechCrunch]] Disrupt San Francisco 2019]] |
[[File:TechCrunch Disrupt San Francisco 2019 - Day 1 (48834421858).jpg|thumb|Dr Katherine Clayton of OmniVis at [[TechCrunch]] Disrupt San Francisco 2019]] |
||
'''OmniVis''' is a [[South San Francisco]] based biotechnology company that specializes in rapid [[Medical diagnosis|medical diagnostic]] tests.<ref name=":0">{{Cite news|last=Joe Palca and Susie Neilson|date=7 Aug 2019|title=This Handy New Device Might Help KO Cholera|language=en|work=NPR.org|url=https://www.npr.org/sections/goatsandsoda/2019/08/07/749100484/this-handy-new-device-might-help-kayo-cholera|access-date=2021-10-31}}</ref><ref>{{Cite web|date=2019-02-15|title=Purdue Spinout OmniVis Commercializing Smartphone-Based Cholera Test|url=https://www.genomeweb.com/pcr/purdue-spinout-omnivis-commercializing-smartphone-based-cholera-test|access-date=2021-11-02|website=Genomeweb|language=en}}</ref><ref>Prashantham, Shameen. Gorillas Can Dance: Lessons from Microsoft and Other Corporations on Partnering with Startups. United Kingdom: Wiley, 2021. p.p. lviii</ref> Co-founded by Dr. Katherine Clayton, a |
'''OmniVis''' is a [[South San Francisco]] based biotechnology company that specializes in rapid [[Medical diagnosis|medical diagnostic]] tests.<ref name=":0">{{Cite news|last=Joe Palca and Susie Neilson|date=7 Aug 2019|title=This Handy New Device Might Help KO Cholera|language=en|work=NPR.org|url=https://www.npr.org/sections/goatsandsoda/2019/08/07/749100484/this-handy-new-device-might-help-kayo-cholera|access-date=2021-10-31}}</ref><ref>{{Cite web|date=2019-02-15|title=Purdue Spinout OmniVis Commercializing Smartphone-Based Cholera Test|url=https://www.genomeweb.com/pcr/purdue-spinout-omnivis-commercializing-smartphone-based-cholera-test|access-date=2021-11-02|website=Genomeweb|language=en}}</ref><ref>Prashantham, Shameen. Gorillas Can Dance: Lessons from Microsoft and Other Corporations on Partnering with Startups. United Kingdom: Wiley, 2021. p.p. lviii</ref> Co-founded by Dr. Katherine Clayton, a Purdue College of Engineering graduate alumna, and three professors, OmniVis produces cholera test and is working on COVID-19 tests. |
||
== Products == |
== Products == |
||
=== Cholera detection === |
=== Cholera detection === |
||
OmnniVis's rapid [[Cholera]] detection device can identify the presence of ''[[Vibrio cholerae]]'' in water in less than one hour.<ref>{{Cite web |last=Service |first=Purdue News |title=‘Cholera detection lab’ smartphone-enabled platform to be beta tested by worldwide leading hospital in cholera research |url=https://www.purdue.edu/newsroom/releases/2019/Q3/cholera-detection-lab-smartphone-enabled-platform-to-be-beta-tested-by-worldwide-leading-hospital-in-cholera-research.html |access-date=2023-11-20 |website=www.purdue.edu |language=en}}</ref> The device uses a process of [[Gene amplification|DNA amplification]] and [[viscosity]] measurement.<ref name=":2">{{Cite web|last=Coldewey|first=Devin|date=2 Oct 2019|title=OmniVis could save lives by detecting cholera-infected water in minutes rather than days|url=https:// |
OmnniVis's rapid [[Cholera]] detection device can identify the presence of ''[[Vibrio cholerae]]'' in water in less than one hour.<ref>{{Cite web |last=Service |first=Purdue News |title=‘Cholera detection lab’ smartphone-enabled platform to be beta tested by worldwide leading hospital in cholera research |url=https://www.purdue.edu/newsroom/releases/2019/Q3/cholera-detection-lab-smartphone-enabled-platform-to-be-beta-tested-by-worldwide-leading-hospital-in-cholera-research.html |access-date=2023-11-20 |website=www.purdue.edu |language=en}}</ref> The device uses a process of [[Gene amplification|DNA amplification]] and [[viscosity]] measurement.<ref name=":2">{{Cite web|last=Coldewey|first=Devin|date=2 Oct 2019|title=OmniVis could save lives by detecting cholera-infected water in minutes rather than days|url=https://techcrunch.com/2019/10/02/omnivis-could-save-lives-by-detecting-cholera-infected-water-in-minutes-rather-than-days/|access-date=2021-10-31|website=TechCrunch|language=en-US}}</ref> |
||
The processing is done via a smartphone enabled platform that analyzes water samples inserted into a single-use test kit element.<ref name=":0" /> In May 2019, OmniVis teamed up with the International Cetre for Diarrhoeal Disease Research, Bangladesh to beta test the technology.<ref name=":0" /> |
The processing is done via a smartphone enabled platform that analyzes water samples inserted into a single-use test kit element.<ref name=":0" /> In May 2019, OmniVis teamed up with the International Cetre for Diarrhoeal Disease Research, Bangladesh to beta test the technology.<ref name=":0" /> |
||
Latest revision as of 04:59, 26 July 2024
 | |
| Industry | Biotechnology |
|---|---|
| Founded | 2017 |
| Headquarters | San Francisco |
Key people | Katherine Clayton, CEO |
| Website | www.omnivistech.com |
.jpg)
OmniVis is a South San Francisco based biotechnology company that specializes in rapid medical diagnostic tests.[1][2][3] Co-founded by Dr. Katherine Clayton, a Purdue College of Engineering graduate alumna, and three professors, OmniVis produces cholera test and is working on COVID-19 tests.
Products
[edit]Cholera detection
[edit]OmnniVis's rapid Cholera detection device can identify the presence of Vibrio cholerae in water in less than one hour.[4] The device uses a process of DNA amplification and viscosity measurement.[5]
The processing is done via a smartphone enabled platform that analyzes water samples inserted into a single-use test kit element.[1] In May 2019, OmniVis teamed up with the International Cetre for Diarrhoeal Disease Research, Bangladesh to beta test the technology.[1]
COVID-19 detection
[edit]In May 2020, OmniVis was working on the early stages of a rapid test for COVID-19[6] that detects the disease in human saliva. The rapid tests uses a smartphone for processing.[6] The project was supported by the United States Department of Agriculture.[7] From June 2020, OmniVis was also working on a United States National Science Foundation funded initiative to detect COVID-19 from nasal swabs.[8]
References
[edit]- ^ a b c Joe Palca and Susie Neilson (7 Aug 2019). "This Handy New Device Might Help KO Cholera". NPR.org. Retrieved 2021-10-31.
- ^ "Purdue Spinout OmniVis Commercializing Smartphone-Based Cholera Test". Genomeweb. 2019-02-15. Retrieved 2021-11-02.
- ^ Prashantham, Shameen. Gorillas Can Dance: Lessons from Microsoft and Other Corporations on Partnering with Startups. United Kingdom: Wiley, 2021. p.p. lviii
- ^ Service, Purdue News. "'Cholera detection lab' smartphone-enabled platform to be beta tested by worldwide leading hospital in cholera research". www.purdue.edu. Retrieved 2023-11-20.
- ^ Coldewey, Devin (2 Oct 2019). "OmniVis could save lives by detecting cholera-infected water in minutes rather than days". TechCrunch. Retrieved 2021-10-31.
- ^ a b Marcus, Brianna Abbott and Amy Dockser (2020-05-26). "Race Is On to Create Rapid Covid-19 Tests for the Fall". Wall Street Journal. ISSN 0099-9660. Retrieved 2021-10-31.
- ^ "COVID-19 Rapid Response: A Handheld Diagnostic Device for COVID-19 in Meat and Poultry Processing Facilities - OMNIVIS INC". portal.nifa.usda.gov. Retrieved 2021-12-17.
- ^ "NSF Award Search: Award # 2028308 - SBIR Phase I: COVID-19 Detection on a Handheld Smartphone-Enabled Platform". www.nsf.gov. Retrieved 2021-12-17.